Compare ELVN & FLNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELVN | FLNC |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 974.7M |
| IPO Year | 2020 | 2021 |
| Metric | ELVN | FLNC |
|---|---|---|
| Price | $28.49 | $16.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | ★ $41.00 | $16.00 |
| AVG Volume (30 Days) | 683.8K | ★ 6.7M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,262,830,000.00 |
| Revenue This Year | N/A | $51.09 |
| Revenue Next Year | N/A | $21.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $3.46 |
| 52 Week High | $30.22 | $33.51 |
| Indicator | ELVN | FLNC |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 31.86 |
| Support Level | $18.41 | $13.96 |
| Resistance Level | $29.63 | $22.93 |
| Average True Range (ATR) | 1.51 | 2.35 |
| MACD | -0.25 | -0.75 |
| Stochastic Oscillator | 64.74 | 2.78 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.